Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

499 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group.
Grünwald V, Bergmann L, Brehmer B, Eberhardt B, Kastrati K, Gauler T, Gehbauer G, Gschwend J, Johannsen M, Klotz T, Protzel C, Schenck M, Staehler M. Grünwald V, et al. Among authors: bergmann l. World J Urol. 2022 Oct;40(10):2381-2386. doi: 10.1007/s00345-022-04015-1. Epub 2022 May 13. World J Urol. 2022. PMID: 35562599 Free PMC article.
A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society.
Bergmann L, Grünwald V, Maute L, Grimm MO, Weikert S, Schleicher J, Klotz T, Greiner J, Flörcken A, Hartmann A, Gauler T. Bergmann L, et al. Oncol Res Treat. 2020;43(7-8):333-339. doi: 10.1159/000508450. Epub 2020 Jun 15. Oncol Res Treat. 2020. PMID: 32541143 Clinical Trial.
499 results